FDA Approves The First Generic Inhaler of Advair Diskus

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.

MedL10N Provides Live Interpretation Services at the 10th DIA China Annual Meeting

From May 23-25, CSOFT’s MedL10N Life Sciences Unit attended and exhibited at the 10th DIA China Conference held at the Beijing International Convention Center. This year’s event attracted thousands of pharmaceutical R&D professionals from around the world to discuss new drug regulations, drug research and development, and the future of the health care industry in China.